CordySeng
Withdrawn from the US market on 7 August 2025 (according to the DSLD)
Health Concerns, food supplement from the US market
Label withdrawn from the US market. CordySeng (Health Concerns), a food supplement au code-barres 810034440372, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- 810034440372
- Form
- Powder
- One serving
- 0.5 teaspoon
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Rice Bran
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Herbal Blend | Blend | 2,396 mg |
| Cordyceps fruiting body extract | Other | not stated |
| Reishi (Ganoderma lucidum) | Plant | not stated |
| Astragalus root extract (Astragalus membranaceus) | Plant | not stated |
| American Ginseng root extract (Panax quinquefolius) | Plant | not stated |
| Licorice Root Extract | Plant | not stated |
| Ginger Root Extract | Plant | not stated |
| Ginger flavor | Other | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: CordySeng
Entered into DSLD on 25 April 2017. On sale on the US market (according to the DSLD).- Active ingredient added : American Ginseng (quantity not stated)
- Active ingredient added : Astragalus (quantity not stated)
- Active ingredient added : Cordyceps (quantity not stated)
- Active ingredient added : Ginger (quantity not stated)
- Active ingredient added : Licorice (quantity not stated)
- Active ingredient added : Proprietary Blend (500 mg)
- Active ingredient added : Red Ganoderma Reishi (quantity not stated)
- Active ingredient removed : American Ginseng root extract (quantity not stated)
- Active ingredient removed : Astragalus root extract (quantity not stated)
- Active ingredient removed : Cordyceps fruiting body extract (quantity not stated)
- Active ingredient removed : Ginger flavor (quantity not stated)
- Active ingredient removed : Ginger Root Extract (quantity not stated)
- Active ingredient removed : Licorice Root Extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (2,396 mg)
- Active ingredient removed : Reishi (quantity not stated)
Official label: CordySeng
Entered into DSLD on 25 April 2017. Withdrawn from the US market on 7 August 2025 (according to the DSLD).- Active ingredient added : Ginger rhizome extract (quantity not stated)
- Active ingredient added : Proprietary Blend (1.2 Gram(s))
- Active ingredient added : Red Ganoderma Reishi (quantity not stated)
- Active ingredient removed : Ginger flavor (quantity not stated)
- Active ingredient removed : Ginger Root Extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (2,396 mg)
- Active ingredient removed : Reishi (quantity not stated)
Official label: CordySeng
Entered into DSLD on 25 June 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : American Ginseng (quantity not stated)
- Active ingredient added : Astragalus (quantity not stated)
- Active ingredient added : Cordyceps (quantity not stated)
- Active ingredient added : Ginger (quantity not stated)
- Active ingredient added : Licorice (quantity not stated)
- Active ingredient added : Proprietary Blend (500 mg)
- Active ingredient added : Red Ganoderma (quantity not stated)
- Active ingredient removed : American Ginseng root extract (quantity not stated)
- Active ingredient removed : Astragalus root extract (quantity not stated)
- Active ingredient removed : Cordyceps fruiting body extract (quantity not stated)
- Active ingredient removed : Ginger flavor (quantity not stated)
- Active ingredient removed : Ginger Root Extract (quantity not stated)
- Active ingredient removed : Licorice Root Extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (2,396 mg)
- Active ingredient removed : Reishi (quantity not stated)
Official label: CordySeng
Entered into DSLD on 25 June 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : Ganoderma (quantity not stated)
- Active ingredient added : Proprietary Blend (1.2 Gram(s))
- Active ingredient removed : Ginger flavor (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (2,396 mg)
- Active ingredient removed : Reishi (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Astragalus root extract
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- American Ginseng root extract
Read the warning, when it applies and the studies cited
PANAX QUINQUEFOLIUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dasgupta A, Kang E, Olsen M, Actor JK, Datta P. Interference of Asian, American, and Indian (Ashwagandha) ginseng in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay. Archives of Pathology & Laboratory Medicine 2007;131(4):619-621. PubMed
- Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. The Annals of Pharmacotherapy 2007;41(10):1617-1624. PubMed
- Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. American ginseng reduces warfarin's effect in healthy patients. Annals of internal medicine 2004;141(1):23-27. PubMed Randomised trial
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dascalu A, Sievenpiper JL, Jenkins AL, Stavro MP, Leiter LA, Arnason JT, Vuksan V. Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals. Canadian Journal of Physiology and Pharmacology 2007;85(9):856-864. PubMed
- Vuksan V, Xu Z, Jenkins AL, Belgan U, Sievenpiper JL, Leiter LA, Josse RG, Stavro MP.American ginseng (Panax quinquefolium L.) improves long-term glycemic control in type 2 diabetes: double-blind placebo controlled crossover trial. Diabetes 2000a;49 (Suppl.1):A95.
Condition of application: All products except Glucose levels and Adaptogen - immune system.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Health Concerns
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.